NO970123D0 - Ny kjemisk forbindelse, dens fremstilling og anvendelse som legemiddel - Google Patents

Ny kjemisk forbindelse, dens fremstilling og anvendelse som legemiddel

Info

Publication number
NO970123D0
NO970123D0 NO970123A NO970123A NO970123D0 NO 970123 D0 NO970123 D0 NO 970123D0 NO 970123 A NO970123 A NO 970123A NO 970123 A NO970123 A NO 970123A NO 970123 D0 NO970123 D0 NO 970123D0
Authority
NO
Norway
Prior art keywords
drug
preparation
chemical compound
new chemical
new
Prior art date
Application number
NO970123A
Other languages
English (en)
Norwegian (no)
Other versions
NO970123L (no
Inventor
Ralf Anderskewitz
Kurt Schromm
Ernst-Otto Renth
Franz Birke
Armin Fuegner
Hubert Heuer
Christopher Meade
Original Assignee
Boehringer Ingelheim Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Kg filed Critical Boehringer Ingelheim Kg
Publication of NO970123L publication Critical patent/NO970123L/no
Publication of NO970123D0 publication Critical patent/NO970123D0/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C257/00—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines
    • C07C257/10—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines
    • C07C257/18—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines having carbon atoms of amidino groups bound to carbon atoms of six-membered aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO970123A 1994-07-13 1997-01-10 Ny kjemisk forbindelse, dens fremstilling og anvendelse som legemiddel NO970123D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4424714A DE4424714A1 (de) 1994-07-13 1994-07-13 Neue chemische Verbindung, ihre Herstellung und ihre Verwendung als Arnzneistoff
PCT/EP1995/002113 WO1996002496A1 (de) 1994-07-13 1995-06-03 Neue chemische verbindung, ihre herstellung und ihre verwendung als arzneistoff

Publications (2)

Publication Number Publication Date
NO970123L NO970123L (no) 1997-01-10
NO970123D0 true NO970123D0 (no) 1997-01-10

Family

ID=6523048

Family Applications (1)

Application Number Title Priority Date Filing Date
NO970123A NO970123D0 (no) 1994-07-13 1997-01-10 Ny kjemisk forbindelse, dens fremstilling og anvendelse som legemiddel

Country Status (25)

Country Link
US (1) US5686496A (hu)
EP (1) EP0770058A1 (hu)
JP (1) JPH10502646A (hu)
KR (1) KR970704674A (hu)
CN (1) CN1152303A (hu)
AU (1) AU2736895A (hu)
BG (1) BG101104A (hu)
BR (1) BR9508395A (hu)
CA (1) CA2194886A1 (hu)
CO (1) CO4410185A1 (hu)
CZ (1) CZ8297A3 (hu)
DE (1) DE4424714A1 (hu)
EE (1) EE9700065A (hu)
FI (1) FI970095A0 (hu)
HR (1) HRP950363A2 (hu)
HU (1) HUT76827A (hu)
IL (1) IL114572A0 (hu)
MX (1) MX9700245A (hu)
NO (1) NO970123D0 (hu)
PE (1) PE35196A1 (hu)
PL (1) PL318114A1 (hu)
SK (1) SK1897A3 (hu)
WO (1) WO1996002496A1 (hu)
YU (1) YU45395A (hu)
ZA (1) ZA955781B (hu)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6191169B1 (en) 1992-08-28 2001-02-20 City Of Hope Human leukocyte 12-lipoxygenase and its role in the pathogenesis of disease states
US6486181B1 (en) 1992-08-28 2002-11-26 City Of Hope Human leukocutye 12-lipoxygenase and its role in the pathogenesis of disease states
AU5857296A (en) * 1995-05-17 1996-11-29 Eli Lilly And Company Use of leukotriene antagonists for alzheimer's disease
DE19546452A1 (de) * 1995-12-13 1997-06-19 Boehringer Ingelheim Kg Neue Phenylamidinderivate, Verfahren zu ihrer Herstelung und ihre Verwendung als Arzneimittel
DE19636689A1 (de) * 1996-09-10 1998-03-12 Boehringer Ingelheim Kg Neue Benzamidinderivate
DE19718334A1 (de) * 1997-04-30 1998-11-05 Boehringer Ingelheim Pharma Neue Benzylaminderivate und Phenylethylaminderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
ID24720A (id) 1997-12-12 2000-08-03 Novartis Ag Senyawa amidino tersubstitusi dalam perawatan penyakit gangguan paru-paru kronis
DE19834713A1 (de) * 1998-07-31 2000-02-03 Boehringer Ingelheim Pharma Neue Phenylethylaminderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
US6528491B2 (en) * 2000-10-24 2003-03-04 Boehringer Ingelheim Pharma Kg Pyranoside derivatives
EP1353661A2 (en) * 2001-01-16 2003-10-22 Boehringer Ingelheim Pharma GmbH & Co.KG Use of an ltb4 antagonist for the treatment and/or prevention of diseases caused by increased expression of mucin genes
IL160208A0 (en) * 2001-08-31 2004-07-25 Neurochem Int Ltd Amidine derivatives for treating amyloidosis
EP1623231A2 (en) * 2003-05-06 2006-02-08 Bayer HealthCare AG Diagnostics and therapeutics for diseases associated with g-protein-coupled receptor ltb4 (ltb4)
US7262223B2 (en) * 2004-01-23 2007-08-28 Neurochem (International) Limited Amidine derivatives for treating amyloidosis
US20080200526A1 (en) * 2004-07-05 2008-08-21 Jin Soo Lee Composition for the Prevention and Treatment of Allergic Inflammatory Disease
JP3983272B2 (ja) * 2004-07-14 2007-09-26 有限会社 炎症研究所 腫瘍転移の抑制方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0518818A3 (en) * 1991-06-11 1993-04-28 Ciba-Geigy Ag Arylethers, their manufacture and use as medicament
HU216191B (hu) * 1992-02-05 1999-05-28 Boehringer Ingelheim Kg Eljárás új amidinszármazékok és ezeket tartalmazó gyógyszerkészítmények előállítására

Also Published As

Publication number Publication date
SK1897A3 (en) 1997-08-06
ZA955781B (en) 1996-02-22
CN1152303A (zh) 1997-06-18
FI970095A (fi) 1997-01-10
EE9700065A (et) 1997-08-15
EP0770058A1 (de) 1997-05-02
WO1996002496A1 (de) 1996-02-01
FI970095A0 (fi) 1997-01-10
US5686496A (en) 1997-11-11
PL318114A1 (en) 1997-05-12
YU45395A (sh) 1997-12-05
IL114572A0 (en) 1995-11-27
HU9700060D0 (en) 1997-02-28
JPH10502646A (ja) 1998-03-10
BG101104A (en) 1998-04-30
AU2736895A (en) 1996-02-16
DE4424714A1 (de) 1996-01-18
HUT76827A (en) 1997-11-28
CO4410185A1 (es) 1997-01-09
PE35196A1 (es) 1996-09-05
HRP950363A2 (en) 1997-08-31
KR970704674A (ko) 1997-09-06
CZ8297A3 (en) 1997-09-17
BR9508395A (pt) 1997-12-23
NO970123L (no) 1997-01-10
MX9700245A (es) 1997-05-31
CA2194886A1 (en) 1996-02-01

Similar Documents

Publication Publication Date Title
FI961219A (fi) Kemialliset yhdisteet, niiden valmistus ja käyttö
DK0966291T3 (da) Medicinsk præparat, som indeholder en lipofil ædelgas
DK0911340T3 (da) Substituerede isoquinolin-3-carboxylsyreamider, deres fremstilling og deres anvendelse som lægemiddel
NO991815D0 (no) Oksadiazoler, fremgangsmÕter for deres fremstilling og deres anvendelse som medikamenter
FI950709A0 (fi) Organometalliset fluorenyyliyhdisteet, valmistus ja käyttö
NO20011216L (no) Azetidinderivater, deres fremstilling og medikamenter inneholdende forbindelsene
DK1119557T3 (da) Indeno-, naphto- og benzocyclohepta-dihydrothiazolderivater, fremstilling deraf og anvendelse deraf som anorektiske medikamenter
NO975513D0 (no) 3-hydroksypyridin-2-karboksylsyreamidester, fremstilling og anvendelse som legemiddel
NO20006138L (no) Substituerte indolinoner, fremstilling og anvendelse derav som medikamenter
EE200000621A (et) Pikornaviirusevastased ühendid, nende valmistamine ja kasutamine
NO970123D0 (no) Ny kjemisk forbindelse, dens fremstilling og anvendelse som legemiddel
DK0828019T3 (da) Sammensat vlies, fremgangsmåde til dens fremstilling og anvendelse deraf
FI941447A0 (fi) Suun kautta annettavat, kapseleina olevat ubidekarenonivalmisteet
NO955306L (no) Metallocenforbindelse og dens anvendelse som katalysatorkomponent
DK155292D0 (da) Kemiske forbindelser, deres fremstilling og anvendelse
DK60593D0 (da) Kemiske forbindelser, deres fremstilling og anvendelse
DK0811593T3 (da) 1,4-diaryl-2-flour-2-buten som insektcider og acaricider
DK1053224T3 (da) Biphenylfulfonylcyanamider, fremgangsmåde til fremstilling deraf og anvendelse deraf som lægemiddel
DK60693D0 (da) Kemiske forbindelser, deres fremstilling og anvendelse
DK60493D0 (da) Kemiske forbindelser, deres fremstilling og anvendelse
NO943860D0 (no) En kjemisk forbindelse og et preparat til bruk som terapeutikum
FI903885A0 (fi) Ny oral farmaceutisk doseringsform som foerbaettrar biotillgaengligheten.
IT1277138B1 (it) Composti tetrakisazoici, loro preparazione e loro impiego come coloranti.
DK93593D0 (da) Kemiske forbindelser, deres fremstilling og anvendelse
DK104393D0 (da) Kemiske forbindelser, deres fremstilling og anvendelse